| |
|
|
| |
Next Generation Transdermal Drug Patches
Evolving Technology, Emerging Opportunities
|
Publication: August 2011
Product Code: NGP956S
|
Transdermal drug patches offer the advantages of ease
of use, painlessness, disposability, control of drug
delivery and avoidance of first-pass metabolism by the
liver. Advances in synthetic materials and patch design have
led to patches that are more esthetically acceptable and
that are capable of delivering sustained dosing of active
compounds for several days in a smaller package.Patches
relying on passive transport mechanisms have been limited in
their ability to deliver new classes of drugs, but
formulations employing penetration enhancers, and patch
designs incorporating microporation and energy-assisted
delivery are expanding the range of drugs that can be
effectively delivered transdermally. Growth in demand for
drug patches is being driven by several factors – factors
with strong demographic and population trend underpinnings.
Further improvements to transdermal transport and the
introduction of new patch designs will keep this segment
expanding through 2015.
. |
|
Highlights |
· Analyzes and evaluates
prescription skin patch products
and assesses risks and market potential
· Analyzes patch designs,
technologies and patch development issues
· Provides
assessments of prescription skin patch products in two
dozen key market segments
· Provides market data
and forecasts to 2015
· Profiles patch
manufacturers, their product development
activities and strategies
|
|
Summary of Contents |
Executive Summary
Market Dynamics
Drug Therapeutics and Self-Administration
Transdermal Drug Delivery Demand Factors
Competitive Landscape
Factors Limiting Growth
Transdermal Drug Patch Development Factors
The Design Cycle
Design Partnerships
Patch
Product Testing
Trials and Submissions
Pharmacokinetics & Dosage Forms
Patch
Manufacturing Dynamics
Patch Design &
Acceptance Factors
Dosing and Rate Factors
Materials Compatibility
Clinical Trial Process
Biocompatibility
New Generation Drug Patch
Products
Patch Products Based on New or
Enhanced Drug Patch Technology
Hydrogels
Microprocessor-based
Microstructures
Phase
Transition
Single-step Applicator-enabled
Two-Step Delivery
Patch Products Based on New
Therapeutic Drug Classes
Metabolic Conditions
Diabetes
Osteoporosis
Narcotic Pain Management
Neurology
Dementia
Migraine
NSAIDs
Peptides
Business and Market Factors
Quality and Reliability
Managed Care and Payor
Initiatives
Skin Patch Revenue Models
Regulatory Factors
Clinical Trial Factors
The
Impact of Generics
Company Profiles
|
|
|
|
|
